DOW INC.
Business
Dow Inc. is a global materials science company that develops, manufactures and markets chemical and polymer solutions for customers across packaging, infrastructure, mobility and consumer applications. The company offers products and technologies including polyolefins and specialty plastics, ethylene and propylene derivatives, silicones and intermediates, coatings, polyurethane systems, adhesives, solvents and performance additives. Its operations are organized into three reportable operating segments—Packaging & Specialty Plastics; Industrial Intermediates & Infrastructure; and Performance Materials & Coatings—plus corporate activities. Dow distributes products worldwide through its sales force, distributors and integrated global manufacturing and joint venture network.
Summary from filing dated 2025-02-04
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net sales | 39,968 | 42,964 | 44,622 | 56,902 | 54,968 | |
| Cost of sales | 37,435 | 38,358 | 39,742 | 48,338 | 44,191 | |
| Research and development expenses | 752 | 810 | 829 | 851 | 857 | |
| Selling, general and administrative expenses | 1,392 | 1,581 | 1,627 | 1,675 | 1,645 | |
| Amortization of intangibles | 231 | 310 | 324 | 336 | 388 | |
| Restructuring, goodwill impairment and asset related charges - net | 1,856 | 103 | 528 | 118 | 6 | |
| Equity in losses of nonconsolidated affiliates | −240 | −6 | −119 | 268 | 975 | |
| Sundry income (expense) - net | 140 | 415 | −280 | 727 | −35 | |
| Interest income | 152 | 200 | 229 | 173 | 55 | |
| Interest expense and amortization of debt discount | 865 | 811 | 746 | 662 | 731 | |
| Income (loss) before income taxes | −2,511 | 1,600 | 656 | 6,090 | 8,145 | |
| Provision (credit) for income taxes | −67 | 399 | −4 | 1,450 | 1,740 | |
| Net income (loss) | −2,444 | 1,201 | 660 | 4,640 | 6,405 | |
| Net income attributable to noncontrolling interests | 179 | 85 | 71 | 58 | 94 | |
| Net income (loss) available for The Dow Chemical Company common stockholder | −2,623 | 1,116 | 589 | 4,582 | 6,311 | |
| Earnings (loss) per common share - basic | −3.7 | 1.57 | 0.82 | 6.32 | 8.44 | |
| Earnings (loss) per common share - diluted | −3.7 | 1.57 | 0.82 | 6.28 | 8.38 | |
| Weighted-average common shares outstanding - basic | 712 | 704 | 706 | 721 | 744 | |
| Weighted-average common shares outstanding - diluted | 712 | 705 | 709 | 726 | 749 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 3,816 | 2,189 | 2,987 | 3,886 | 2,988 | |
| Trade (net of allowance for doubtful receivables - 2025: $59; 2024: $95) | 4,762 | 4,756 | 4,718 | 5,611 | 6,841 | |
| Other Receivables | 1,876 | 2,108 | 1,896 | 2,144 | 2,713 | |
| Inventories | 6,595 | 6,544 | 6,076 | 6,988 | 7,372 | |
| Other current assets | 1,013 | 993 | 1,937 | 1,848 | 934 | |
| Total current assets (variable interest entities restricted - 2025: $228; 2024: $55) | 18,062 | 16,590 | 17,614 | 20,477 | 20,848 | |
| Investment in nonconsolidated affiliates | 1,264 | 1,266 | 1,267 | 1,589 | 2,045 | |
| Other investments (investments carried at fair value - 2025: $2,212; 2024: $2,047) | 3,017 | 3,033 | 2,740 | 2,793 | 3,193 | |
| Noncurrent receivables | 309 | 380 | 438 | 666 | 478 | |
| Total investments | 4,590 | 4,679 | 4,445 | 5,048 | 5,716 | |
| Property | 65,863 | 62,121 | 60,203 | 58,055 | 57,604 | |
| Less: Accumulated depreciation | 43,613 | 40,117 | 39,137 | 37,613 | 37,049 | |
| Net property | 22,250 | 22,004 | 21,066 | 20,442 | 20,555 | |
| Goodwill | 7,978 | 8,565 | 8,641 | 8,644 | 8,764 | |
| Other intangible assets (net of accumulated amortization - 2025: $5,727; 2024: $5,394) | 1,486 | 1,721 | 2,072 | 2,442 | 2,881 | |
| Operating lease right-of-use assets | 1,356 | 1,268 | 1,320 | 1,227 | 1,412 | |
| Deferred income tax assets | 1,511 | 1,257 | 1,486 | 960 | 1,358 | |
| Deferred charges and other assets | 1,305 | 1,228 | 1,323 | 1,363 | 1,456 | |
| Total other assets (variable interest entities restricted - 2025: $226; 2024: $15) | 13,636 | 14,039 | 14,842 | 14,636 | 15,871 | |
| Total Assets | 58,538 | 57,312 | 57,967 | 60,603 | 62,990 | |
| Notes payable | 90 | 135 | 62 | 362 | 161 | |
| Long-term debt due within one year | 222 | 497 | 117 | 362 | 231 | |
| Accounts Payable, Trade | 4,151 | 4,847 | 4,529 | 4,940 | 5,577 | |
| Accounts Payable, Other | 1,394 | 1,694 | 1,797 | 2,276 | 2,839 | |
| Operating lease liabilities - current | 340 | 318 | 329 | 287 | 314 | |
| Income taxes payable | 337 | 276 | 419 | 334 | 623 | |
| Accrued and other current liabilities | 2,649 | 2,521 | 2,704 | 2,770 | 3,481 | |
| Total current liabilities (variable interest entities restricted - 2025: $438; 2024: $24) | 9,183 | 10,288 | 9,957 | 11,331 | 13,226 | |
| Long-Term Debt (variable interest entities restricted - 2025: $190; 2024: $) | 17,849 | 15,711 | 14,907 | 14,698 | 14,280 | |
| Deferred income tax liabilities | 364 | 392 | 399 | 1,110 | 506 | |
| Pension and other postretirement benefits - noncurrent | 4,694 | 4,736 | 4,932 | 3,808 | 7,557 | |
| Asbestos-related liabilities - noncurrent | 628 | 713 | 788 | 857 | 931 | |
| Operating lease liabilities - noncurrent | 1,097 | 984 | 1,032 | 997 | 1,149 | |
| Other noncurrent obligations | 7,201 | 6,637 | 6,844 | 6,555 | 6,602 | |
| Total other noncurrent liabilities (variable interest entities restricted - 2025: $364; 2024: $13) | 13,984 | 13,462 | 13,995 | 13,327 | 16,745 | |
| Common stock (authorized and issued 100 shares of $0.01 par value each) | 8 | 8 | 8 | 8 | 8 | |
| Additional paid-in capital | 11,112 | 9,203 | 8,880 | 8,540 | 8,151 | |
| Retained earnings | 16,781 | 20,909 | 21,774 | 23,180 | 20,623 | |
| Accumulated other comprehensive loss | −7,660 | −8,110 | −7,681 | −7,139 | −8,977 | |
| Treasury stock at cost (2025: 73,065,152 shares; 2024: 80,859,145 shares) | −4,233 | −4,655 | −4,374 | −3,871 | −1,625 | |
| Dow Inc.s stockholders equity | 16,008 | 17,355 | 18,607 | 20,718 | 18,165 | |
| Noncontrolling interests | 1,514 | 496 | 501 | 529 | 574 | |
| Total equity | 17,522 | 17,851 | 19,108 | 21,247 | 18,739 | |
| Total Liabilities and Equity | 58,538 | 57,312 | 57,967 | 60,603 | 62,990 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net income (loss) | −2,444 | 1,201 | 660 | 4,640 | 6,405 | |
| Depreciation and amortization | 2,834 | 2,894 | 2,611 | 2,758 | 2,842 | |
| Provision (Credit) for deferred income tax | −341 | 135 | −1,222 | 79 | 278 | |
| Earnings of nonconsolidated affiliates less than (in excess of) dividends received | 439 | 348 | 387 | 696 | −651 | |
| Net periodic pension benefit cost | −95 | −210 | 548 | 23 | 39 | |
| Pension contributions | −209 | −121 | −142 | −235 | −1,219 | |
| Net gain on sales of assets, businesses and investments | −220 | −65 | −70 | −19 | −105 | |
| Restructuring, goodwill impairment and asset related charges - net | 1,856 | 103 | 528 | 118 | 6 | |
| Other net loss | 440 | 239 | 796 | 212 | 921 | |
| Accounts and notes receivable | 73 | −224 | 1,161 | 1,187 | −2,132 | |
| Inventories | −52 | −529 | 844 | 347 | −1,768 | |
| Accounts payable | −999 | 278 | −734 | −1,255 | 2,458 | |
| Other assets and liabilities, net | −220 | −1,146 | −203 | −1,065 | −5 | |
| Cash provided by operating activities - continuing operations | 1,062 | 2,903 | 5,164 | 7,486 | 7,069 | |
| Cash provided by (used for) operating activities - discontinued operations | −30 | 11 | 32 | −11 | −60 | |
| Cash provided by (used for) operating activities | 1,032 | 2,914 | 5,196 | 7,475 | 7,009 | |
| Capital expenditures | −2,479 | −2,940 | −2,356 | −1,823 | −1,501 | |
| Proceeds from incentives related to capital expenditures | 145 | 0 | 0 | — | — | |
| Cash flow hedging related to capital expenditures | −40 | 0 | 0 | — | — | |
| Investment in gas field developments | −157 | −203 | −215 | −190 | −92 | |
| Purchases of previously leased assets | 0 | 0 | −7 | −7 | −694 | |
| Proceeds from sales of property and businesses, net of cash divested | 139 | 234 | 95 | 32 | 68 | |
| Acquisitions of property and businesses, net of cash acquired | 0 | −125 | −114 | −228 | −129 | |
| Investments in and loans to nonconsolidated affiliates | −32 | −28 | −5 | −148 | 0 | |
| Distributions and loan repayments from nonconsolidated affiliates | 0 | 0 | 2 | 52 | 51 | |
| Proceeds from Sale of Equity Method Investments | 125 | 0 | 63 | 11 | 0 | |
| Purchases of investments | −881 | −1,809 | −2,288 | −1,366 | −1,366 | |
| Proceeds from sales and maturities of investments | 1,022 | 2,536 | 1,958 | 747 | 759 | |
| Other investing activities, net | 32 | −33 | −61 | −50 | −10 | |
| Cash provided by (used for) investing activities | −2,126 | −2,368 | −2,928 | −2,970 | −2,914 | |
| Changes in short-term notes payable | −5 | −61 | −249 | 253 | −48 | |
| Proceeds from Short-term Debt, Maturing in More than Three Months | 64 | 143 | 0 | 0 | 144 | |
| Repayments of Short-term Debt, Maturing in More than Three Months | −63 | −17 | 0 | −14 | −130 | |
| Proceeds from issuance of long-term debt | 2,778 | 1,467 | 104 | 1,667 | 109 | |
| Payments on long-term debt | −1,461 | −267 | −446 | −1,006 | −2,771 | |
| Proceeds from (Repayments of) Accounts Receivable Securitization | −9 | −9 | 18 | 0 | — | |
| Purchases of treasury stock | 0 | −494 | −625 | −2,325 | −1,000 | |
| Proceeds from issuance of parent company stock | 85 | 166 | 188 | 212 | 320 | |
| Transaction financing, debt issuance and other costs | −137 | −14 | −2 | −24 | −537 | |
| Employee taxes paid for share-based payment arrangements | −18 | −39 | −42 | −35 | −12 | |
| Distributions to noncontrolling interests | −173 | −77 | −89 | −83 | −73 | |
| Proceeds from Noncontrolling Interests | 2,943 | 0 | 0 | — | — | |
| Dividends paid to stockholders | −1,490 | −1,966 | −1,972 | −2,006 | −2,073 | |
| Other financing activities, net | −6 | 0 | 0 | — | — | |
| Cash used for financing activities | 2,508 | −1,168 | −3,115 | −3,361 | −6,071 | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 275 | −163 | −45 | −237 | −99 | |
| Increase (decrease) in cash, cash equivalents and restricted cash | 1,689 | −785 | −892 | 907 | −2,075 |